Amita Sharma, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiography, Interventional | 4 | 2019 | 1095 | 1.460 |
Why?
|
| Lung | 13 | 2021 | 9826 | 1.180 |
Why?
|
| Biopsy, Needle | 3 | 2019 | 1640 | 1.040 |
Why?
|
| Pseudohypoparathyroidism | 3 | 2017 | 90 | 0.780 |
Why?
|
| Multiple Pulmonary Nodules | 2 | 2019 | 153 | 0.730 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2021 | 20086 | 0.680 |
Why?
|
| Lung Neoplasms | 10 | 2021 | 13019 | 0.630 |
Why?
|
| Lung Diseases | 3 | 2019 | 1884 | 0.590 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2019 | 273 | 0.570 |
Why?
|
| Dyspnea | 4 | 2021 | 1298 | 0.530 |
Why?
|
| Nephrocalcinosis | 2 | 2014 | 48 | 0.510 |
Why?
|
| Metatarsal Bones | 1 | 2015 | 107 | 0.500 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 265 | 0.470 |
Why?
|
| Hemoptysis | 4 | 2019 | 155 | 0.450 |
Why?
|
| Hypernatremia | 1 | 2012 | 82 | 0.410 |
Why?
|
| Bartter Syndrome | 1 | 2011 | 24 | 0.400 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 959 | 0.390 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2011 | 150 | 0.370 |
Why?
|
| Calcitriol | 2 | 2011 | 298 | 0.360 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 1967 | 0.340 |
Why?
|
| Kidney | 4 | 2018 | 7167 | 0.330 |
Why?
|
| Preoperative Care | 1 | 2017 | 2245 | 0.310 |
Why?
|
| Chromogranins | 2 | 2017 | 163 | 0.270 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 1527 | 0.250 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 2 | 2017 | 202 | 0.250 |
Why?
|
| Pneumothorax | 2 | 2019 | 379 | 0.240 |
Why?
|
| Radiography, Thoracic | 2 | 2020 | 1265 | 0.230 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2021 | 451 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
| Syntaxin 16 | 2 | 2017 | 12 | 0.190 |
Why?
|
| Diagnosis, Differential | 10 | 2021 | 12958 | 0.190 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 61 | 0.180 |
Why?
|
| Hemothorax | 1 | 2019 | 59 | 0.180 |
Why?
|
| Nephrotic Syndrome | 2 | 2017 | 389 | 0.170 |
Why?
|
| Chest Tubes | 1 | 2019 | 150 | 0.170 |
Why?
|
| Thoracic Wall | 1 | 2019 | 201 | 0.150 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIc | 2 | 2014 | 15 | 0.150 |
Why?
|
| Hydroxyurea | 1 | 2018 | 290 | 0.150 |
Why?
|
| Cough | 1 | 2020 | 555 | 0.140 |
Why?
|
| Hypocalcemia | 2 | 2015 | 191 | 0.140 |
Why?
|
| Temporal Arteries | 1 | 2017 | 128 | 0.130 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2016 | 82 | 0.130 |
Why?
|
| Albuminuria | 1 | 2018 | 683 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 7276 | 0.120 |
Why?
|
| Humans | 38 | 2021 | 742088 | 0.120 |
Why?
|
| Rickets | 2 | 2012 | 74 | 0.120 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 665 | 0.120 |
Why?
|
| Early Detection of Cancer | 2 | 2020 | 3070 | 0.120 |
Why?
|
| Salicylates | 1 | 2014 | 126 | 0.120 |
Why?
|
| Base Sequence | 3 | 2015 | 12797 | 0.120 |
Why?
|
| Female | 25 | 2021 | 379592 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14720 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 526 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 971 | 0.120 |
Why?
|
| Pleura | 1 | 2015 | 235 | 0.120 |
Why?
|
| Podocytes | 1 | 2017 | 394 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 962 | 0.110 |
Why?
|
| Gadolinium | 1 | 2018 | 951 | 0.110 |
Why?
|
| Thymus Neoplasms | 1 | 2015 | 268 | 0.110 |
Why?
|
| Adolescent | 13 | 2018 | 85649 | 0.110 |
Why?
|
| Vasculitis | 1 | 2017 | 521 | 0.110 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 471 | 0.110 |
Why?
|
| Hypercalciuria | 1 | 2012 | 31 | 0.110 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2012 | 62 | 0.110 |
Why?
|
| Ureter | 1 | 2015 | 374 | 0.110 |
Why?
|
| Hypophosphatemia, Familial | 1 | 2012 | 34 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 2015 | 880 | 0.110 |
Why?
|
| Acidosis | 1 | 2014 | 272 | 0.110 |
Why?
|
| Fanconi Syndrome | 1 | 2012 | 35 | 0.110 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 421 | 0.110 |
Why?
|
| Hypokalemia | 1 | 2013 | 153 | 0.100 |
Why?
|
| Urinary Tract | 1 | 2015 | 308 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1517 | 0.100 |
Why?
|
| Breast Diseases | 1 | 2015 | 443 | 0.100 |
Why?
|
| Muscle, Smooth | 1 | 2015 | 933 | 0.100 |
Why?
|
| Hyperkalemia | 1 | 2013 | 218 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 1526 | 0.100 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1927 | 0.100 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1093 | 0.090 |
Why?
|
| Anemia, Sickle Cell | 1 | 2018 | 1017 | 0.090 |
Why?
|
| Homocystinuria | 1 | 2010 | 67 | 0.090 |
Why?
|
| Pedigree | 3 | 2015 | 4646 | 0.090 |
Why?
|
| Incidental Findings | 1 | 2015 | 688 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2018 | 1155 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5062 | 0.090 |
Why?
|
| Kidney Calculi | 1 | 2014 | 465 | 0.090 |
Why?
|
| Middle Aged | 11 | 2021 | 213127 | 0.090 |
Why?
|
| Liver Failure, Acute | 1 | 2010 | 165 | 0.080 |
Why?
|
| Retrospective Studies | 7 | 2019 | 77098 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4839 | 0.080 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2009 | 110 | 0.080 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1792 | 0.080 |
Why?
|
| Skin Diseases | 1 | 2017 | 1065 | 0.080 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 57683 | 0.080 |
Why?
|
| Leukoencephalopathies | 1 | 2010 | 238 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2145 | 0.080 |
Why?
|
| Steroid Hydroxylases | 1 | 2007 | 96 | 0.070 |
Why?
|
| Aged | 9 | 2021 | 162944 | 0.070 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2008 | 86 | 0.070 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2013 | 979 | 0.070 |
Why?
|
| Male | 18 | 2021 | 349538 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 4414 | 0.070 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 1199 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 8925 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 4554 | 0.060 |
Why?
|
| Acute Disease | 1 | 2015 | 7141 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3144 | 0.060 |
Why?
|
| Alleles | 1 | 2015 | 6931 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 19862 | 0.060 |
Why?
|
| Heterozygote | 1 | 2011 | 2790 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 3617 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2015 | 3461 | 0.060 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 802 | 0.060 |
Why?
|
| Biopsy | 3 | 2021 | 6756 | 0.060 |
Why?
|
| Prevalence | 1 | 2019 | 15194 | 0.050 |
Why?
|
| Mutation | 4 | 2018 | 29717 | 0.050 |
Why?
|
| Child, Preschool | 5 | 2018 | 40955 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7873 | 0.050 |
Why?
|
| Critical Illness | 1 | 2013 | 2665 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8328 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3239 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2020 | 2485 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 35342 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2008 | 2161 | 0.040 |
Why?
|
| Infant | 6 | 2018 | 35070 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2021 | 695 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2021 | 1183 | 0.040 |
Why?
|
| Child | 6 | 2018 | 77478 | 0.040 |
Why?
|
| Organizational Innovation | 1 | 2020 | 559 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4200 | 0.040 |
Why?
|
| Hypergammaglobulinemia | 1 | 2017 | 74 | 0.040 |
Why?
|
| Iodine | 1 | 2019 | 285 | 0.040 |
Why?
|
| Gallbladder | 1 | 2018 | 301 | 0.040 |
Why?
|
| Societies, Medical | 2 | 2021 | 3740 | 0.040 |
Why?
|
| Sweating | 1 | 2017 | 123 | 0.040 |
Why?
|
| Ascites | 1 | 2018 | 344 | 0.030 |
Why?
|
| Exons | 2 | 2015 | 2431 | 0.030 |
Why?
|
| Headache | 2 | 2017 | 1219 | 0.030 |
Why?
|
| Alveolitis, Extrinsic Allergic | 1 | 2016 | 61 | 0.030 |
Why?
|
| Contrast Media | 2 | 2019 | 5295 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2008 | 2370 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 300 | 0.030 |
Why?
|
| Observer Variation | 1 | 2021 | 2593 | 0.030 |
Why?
|
| Lethargy | 1 | 2014 | 39 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 898 | 0.030 |
Why?
|
| Program Development | 1 | 2020 | 1314 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 3639 | 0.030 |
Why?
|
| Poisoning | 1 | 2014 | 249 | 0.030 |
Why?
|
| Prescriptions | 1 | 2015 | 387 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 905 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2008 | 4595 | 0.030 |
Why?
|
| Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2012 | 44 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 72145 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15056 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2017 | 4282 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 192 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 395 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2018 | 5978 | 0.020 |
Why?
|
| Diarrhea | 1 | 2018 | 1343 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18112 | 0.020 |
Why?
|
| Artifacts | 1 | 2019 | 1903 | 0.020 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 484 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1171 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2012 | 417 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2015 | 770 | 0.020 |
Why?
|
| Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Actins | 1 | 2017 | 2120 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2012 | 642 | 0.020 |
Why?
|
| Fatigue | 1 | 2017 | 1526 | 0.020 |
Why?
|
| Anemia | 1 | 2018 | 1499 | 0.020 |
Why?
|
| Fever | 1 | 2016 | 1612 | 0.020 |
Why?
|
| Nephritis | 1 | 2009 | 158 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2012 | 956 | 0.020 |
Why?
|
| Abdomen | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2016 | 807 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8662 | 0.020 |
Why?
|
| Oocytes | 1 | 2012 | 1186 | 0.020 |
Why?
|
| Family Health | 1 | 2012 | 1282 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 56350 | 0.020 |
Why?
|
| Research | 1 | 2015 | 1999 | 0.020 |
Why?
|
| Lymphoma | 1 | 2015 | 1873 | 0.020 |
Why?
|
| Forecasting | 1 | 2015 | 2948 | 0.020 |
Why?
|
| Nausea | 1 | 2009 | 665 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2015 | 1162 | 0.020 |
Why?
|
| Adult | 5 | 2021 | 213712 | 0.020 |
Why?
|
| Seizures | 2 | 2009 | 2851 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2604 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2275 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 2014 | 1780 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2556 | 0.020 |
Why?
|
| Introns | 1 | 2007 | 991 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 8333 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4801 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 748 | 0.010 |
Why?
|
| Femoral Fractures | 1 | 2007 | 376 | 0.010 |
Why?
|
| Cell Line | 1 | 2017 | 15994 | 0.010 |
Why?
|
| DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
| Health Personnel | 1 | 2015 | 3210 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11363 | 0.010 |
Why?
|
| Decision Making | 1 | 2015 | 3869 | 0.010 |
Why?
|
| Radiology | 1 | 2015 | 2090 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2016 | 9144 | 0.010 |
Why?
|
| Chest Pain | 1 | 2008 | 1113 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2015 | 3738 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21719 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 13814 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9305 | 0.010 |
Why?
|
| Registries | 1 | 2015 | 8077 | 0.010 |
Why?
|
| Length of Stay | 1 | 2013 | 6294 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 9735 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4929 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2007 | 2751 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 8969 | 0.010 |
Why?
|
| Mice | 2 | 2017 | 81045 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 6540 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15530 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 40450 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12220 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 168561 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 7289 | 0.010 |
Why?
|
| Hypertension | 1 | 2009 | 8455 | 0.010 |
Why?
|
| United States | 1 | 2015 | 69693 | 0.000 |
Why?
|
| Brain | 1 | 2009 | 26343 | 0.000 |
Why?
|